Pure bone marrow aspirate injection for chronic Greater Trochanteric Pain Syndrome: a case report
Rachel G Henderson, Ricardo E Colberg.
Pain Manag. 2018 Jul 1;8(4):271-275 | doi: 10.2217/pmt-2018-0008
Henderson and Colberg from Andrews Sports Medicine & Orthopedic Center in Birmingham (AL, USA) show a case of a patient with a debilitating greater trochnaderic pain syndrome that was treated with a Marrow Cellution harvested pure autologous bone marrow aspirate injection into the tendon, and reported near complete resolution of symptoms at 1-year follow-up.
- Orthobiologic interventions, such as platelet-rich plasma and bone marrow aspirate injections, may stimulate tendon healing and improve pain and function in patients who fail conservative treatment with the current standard of care.
- Given growing concerns with regards to the current bone marrow aspirate concentrate procedure technique, a new technique for aspirating the bone marrow has been introduced.
Henderson RG, Colberg RE. Pure bone marrow aspirate injection for chronic greater trochanteric pain syndrome: a case report. Pain Manag. 2018 Jul 1;8(4):271-275 (doi: 10.2217/pmt-2018-0008);
______________________________________________________
The Marrow Cellution™ System is designed to minimize and eliminate the restrictive limitations associated with “point of care” processing systems which employ inefficient traditional aspiration trocar technology and are regulated as drugs “Advanced Therapies Medicinal Products (ATMP)”. Marrow Cellution™ is a minimally invasive bone/cell enriched autograft access and retrieval system, which does not require additional manipulation or processing, it never leaves the sterile field and provides rich autograft without associated morbidity.
Visit our Marrow Cellution product page
